Oncolys, Kyoto Pref. University of Medicine to Study OBP-801 for Glaucoma

Oncolys BioPharma said on August 18 that it will collaborate with Kyoto Prefectural University of Medicine in research on the potential use of OBP-801, which is being developed as an anticancer drug, for glaucoma surgery. OBP-801 is a histone deacetylase...read more